
MIDDLETOWN – A Chinese pharmaceutical company is steadily preparing for its $515 million Middletown campus as Delaware officials continue to wait on whether or not Merck will select the state for its next pharmaceutical plant.
Earlier this year, WuXi AppTec made moves to sell off U.S. and United Kingdom therapies units as well as medical device testing amid uncertainty over proposed…
…
Continue reading this article at;
https://delawarebusinesstimes.com/news/wuxi-middletown-still-on-schedule/
delawarebusinesstimes.com
Feed Name : Delaware Business Times
Bioscience & Pharmaceutical,Insider Only,New Castle County,News
hashtags : #WuXi #Middletown #pharma #campus #schedule